Analyst Ratings for Sequenom (SQNM)
SQNM Rating Summary
SQNM Price Target Summary
- Highest: $10.00 (Oppenheimer)
- Lowest: $5.00 (Wedbush)
- Average: $7.11
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.11 (+73.4%)
Avg. $ Target:
$7.11 (+73.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2013 | Credit Suisse | Upgrade | Neutral (Underperform) |
N/A (N/A) |
4.04 | 4.10 | 1.49% | Details |
| 4/4/2013 | Wedbush | Upgrade | Outperform (Neutral) |
5.00 (N/A) |
3.87 | 4.10 | 5.94% | Details |
| 3/1/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
6.50 (5.00) |
4.11 | 4.10 | -0.24% | Details |
| 11/26/2012 | Stephens | Upgrade | Overweight (Equal Weight) |
N/A (N/A) |
4.26 | 4.10 | -3.76% | Details |
| 11/12/2012 | Jefferies » Updated 11/21/2012 |
Upgrade | Buy (Hold) |
7.00 (7.00) |
3.60 | 4.10 | 13.89% | Details |
| 6/19/2012 | Maxim Group | New Coverage | Buy (N/A) |
6.00 (N/A) |
3.70 | 4.10 | 10.81% | Details |
| 1/5/2012 | Dougherty & Co » Updated 9/11/2012 |
New Coverage | Buy (N/A) |
6.50 (N/A) |
4.28 | 4.10 | -4.21% | Details |
| 8/26/2011 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
5.39 | 4.10 | -23.93% | Details |
| 5/6/2011 | Auriga » Updated 3/8/2012 |
New Coverage | Buy (N/A) |
8.00 (N/A) |
7.01 | 4.10 | -41.51% | Details |
| 3/17/2011 | Oppenheimer » Updated 1/7/2013 |
New Coverage | Outperform (N/A) |
10.00 (10.00) |
5.62 | 4.10 | -27.05% | Details |
| 2/11/2011 | Rodman & Renshaw | Upgrade | Market Perform (N/A) |
N/A (N/A) |
7.19 | 4.10 | -42.98% | Details |
| 8/4/2010 | Soleil Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
5.92 | 4.10 | -30.74% | Details |
| 7/21/2010 | Ladenburg Thalmann | Upgrade | Buy (N/A) |
N/A (N/A) |
5.69 | 4.10 | -27.94% | Details |
